To answer these important questions and to guide clinical practice, this study investigated the sequential value of biochemical measures (Figure 1), i.e., first, platelet count, then CRP, then ESR, in evaluating the risk of GCA in patients presenting relevant symptoms. This evidence concerns the gene CRP and temporal arteritis.